4.09
+0.01(+0.25%)
Currency In USD
| Previous Close | 4.08 |
| Open | 4.08 |
| Day High | 4.09 |
| Day Low | 4.01 |
| 52-Week High | 100.8 |
| 52-Week Low | 2.77 |
| Volume | 33,200 |
| Average Volume | 1.9M |
| Market Cap | 8.8M |
| PE | -0.25 |
| EPS | -16.41 |
| Moving Average 50 Days | 4.39 |
| Moving Average 200 Days | 9.29 |
| Change | 0.01 |
If you invested $1000 in HCW Biologics Inc. (HCWB) since IPO date, it would be worth $649.21 as of September 29, 2025 at a share price of $4.09. Whereas If you bought $1000 worth of HCW Biologics Inc. (HCWB) shares 3 years ago, it would be worth $43.33 as of September 29, 2025 at a share price of $4.09.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
HCW Biologics, a Shareholder of Wugen, Congratulates Wugen on Its Recent Successful Equity Financing
GlobeNewswire Inc.
Sep 18, 2025 1:15 PM GMT
Wugen closed a $115 million equity financing led by Fidelity Management & Research Company HCW Biologics holds a minority equity interest in Wugen MIRAMAR, Fla., Sept. 18, 2025 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologic
HCW Biologics Designates One of Its Proprietary TRBC-Pembrolizumab-Based Immune Checkpoint Inhibitors as its Franchise Immunotherapeutic for Internal Clinical Development
GlobeNewswire Inc.
Sep 16, 2025 12:00 PM GMT
Lead product candidate will be advanced to late IND-enabling studies to prepare for clinical trials for evaluation in the treatment of solid tumors Discovery of unique combination of cytokines in multi-functional fusion protein molecule that exhibits
HCW Biologics Reports Positive Results from Non-Human Primate Study for Its Proprietary Second-Generation T-Cell Engager Program
GlobeNewswire Inc.
Sep 09, 2025 12:00 PM GMT
HCW Biologics conducted investigative study to show safe dose levels of its lead drug candidate in non-human primates that were well tolerated at a level significantly higher than the identified efficacious dose level Program has addressed key challe